ARTICLE | Clinical News
Xiapex regulatory update
August 15, 2011 7:00 AM UTC
Auxilium disclosed in its 2Q11 earnings that Swissmedic approved Xiapex collagenase clostridium histolyticum to treat Dupuytren's contracture in adult patients with a palpable cord. Pfizer Inc. (NYSE...